bf/NASDAQ:CERS_icon.jpeg

NASDAQ:CERS

Cerus Corporation

  • Stock

USD

Last Close

1.41

06/11 22:23

Market Cap

345.74M

Beta: 1.03

Volume Today

880.51K

Avg: 1.44M

PE Ratio

−6.88

PFCF: −9.65

    Description

    Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.15-0.1-0.052019-02-262020-10-292022-05-052024-03-052025-03-04

    Revenue (Estimate*)

    10M20M30M40M50M2019-02-262020-10-292022-05-052024-03-052025-03-04

    *Estimate based on analyst consensus